A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito.
BACKGROUND
Up to 40% of the world's population is at risk for Plasmodium vivax malaria, a disease that imposes a major public health and economic burden on endemic countries. Because P. vivax produces latent liver forms, eradication of P. vivax malaria is more challenging than it is for P. falciparum. Genetic analysis of P. vivax is exceptionally difficult due to limitations of in vitro culture. To overcome the barriers to traditional molecular biology in P. vivax, we examined parasite transcriptional changes in samples from infected patients and mosquitoes in order to characterize gene function, define regulatory sequences and reveal new potential vaccine candidate genes.


RESULTS
We observed dramatic changes in transcript levels for various genes at different lifecycle stages, indicating that development is partially regulated through modulation of mRNA levels. Our data show that genes involved in common biological processes or molecular machinery are co-expressed. We identified DNA sequence motifs upstream of co-expressed genes that are conserved across Plasmodium species that are likely binding sites of proteins that regulate stage-specific transcription. Despite their capacity to form hypnozoites we found that P. vivax sporozoites show stage-specific expression of the same genes needed for hepatocyte invasion and liver stage development in other Plasmodium species. We show that many of the predicted exported proteins and members of multigene families show highly coordinated transcription as well.


CONCLUSIONS
We conclude that high-quality gene expression data can be readily obtained directly from patient samples and that many of the same uncharacterized genes that are upregulated in different P. vivax lifecycle stages are also upregulated in similar stages in other Plasmodium species. We also provide numerous examples of how systems biology is a powerful method for determining the likely function of genes in pathogens that are neglected due to experimental intractability.
Westenberger
Scott J
SJ
Department of Cell Biology ICND 202, The Scripps Research Institute, La Jolla, California, United States of America.
McClean
Colleen M
CM
Chattopadhyay
Rana
R
Dharia
Neekesh V
NV
Carlton
Jane M
JM
Barnwell
John W
JW
Collins
William E
WE
Hoffman
Stephen L
SL
Zhou
Yingyao
Y
Vinetz
Joseph M
JM
Winzeler
Elizabeth A
EA
D000818:Animals; D009033:Culicidae / Q000469:parasitology*; D020869:Gene Expression Profiling; D006801:Humans; D008018:Life Cycle Stages; D016780:Malaria, Vivax / Q000469:parasitology*; D010966:Plasmodium vivax / Q000235:genetics* / Q000472:pathogenicity*
J Biol Chem. 2005 Oct 7;280(40):34245-58
16002398
Science. 2004 Dec 10;306(5703):1934-7
15591203
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3022-7
15699336
Nature. 2001 Apr 12;410(6830):839-42
11298455
J Parasitol. 2001 Dec;87(6):1398-403
11780828
Lancet Infect Dis. 2009 Sep;9(9):555-66
19695492
Am J Trop Med Hyg. 1972 Sep;21(5):707-12
4627547
PLoS One. 2008;3(11):e3779
19020666
Nature. 2005 Jan 13;433(7022):164-7
15580261
Eukaryot Cell. 2006 Oct;5(10):1622-34
17030994
PLoS Med. 2008 Jun 17;5(6):e128
18563962
Nature. 2008 Oct 9;455(7214):757-63
18843361
J Exp Med. 1999 Dec 6;190(11):1711-6
10587361
Mol Cell. 2007 Oct 26;28(2):337-50
17964271
Vaccine. 2008 Jul 23;26(31):3787-94
18579264
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8393-8
18541913
Mol Biochem Parasitol. 2006 Sep;149(1):99-101
16716418
Mol Biochem Parasitol. 2007 Nov;156(1):51-61
17719658
Mol Biochem Parasitol. 2005 Aug;142(2):158-69
15869815
BMC Bioinformatics. 2004 Apr 20;5:42
15099405
J Exp Med. 2005 Jul 18;202(2):225-30
16027235
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9952-7
12886016
PLoS One. 2009;4(1):e4285
19173007
Mol Cell. 2000 Oct;6(4):861-71
11090624
Nat Protoc. 2007;2(10):2366-82
17947979
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7559-64
19376968
Nature. 2002 Oct 3;419(6906):520-6
12368866
Science. 2003 Sep 12;301(5639):1503-8
12893887
Eur J Biochem. 1994 Sep 1;224(2):397-405
7925353
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9114-8
2904149
EMBO J. 1998 Sep 15;17(18):5418-26
9736619
Genome Res. 2004 Nov;14(11):2308-18
15520293
PLoS Med. 2008 Jun 17;5(6):e136
18563965
Proteomics. 2008 Nov;8(22):4680-94
18937256
Bioinformatics. 2005 Apr 1;21(7):1237-45
15531612
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
15075390
Genome Biol. 2006;7(2):R12
16507167
Mol Microbiol. 2009 Mar;71(6):1402-14
19220746
Mol Biochem Parasitol. 2007 Nov;156(1):32-40
17714805
Am J Trop Med Hyg. 1949 Sep;29(5):701-5
18141389
EMBO J. 1999 Nov 15;18(22):6221-7
10562534
Mol Microbiol. 2005 Nov;58(3):648-58
16238616
J Biol Chem. 2002 Nov 1;277(44):41948-53
12177071
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12194-9
16103357
Mol Biochem Parasitol. 2005 Sep;143(1):67-79
16005087
Pharmacol Rev. 2005 Mar;57(1):117-45
15734729
Curr Opin Infect Dis. 2009 Oct;22(5):430-5
19571748
Nature. 2007 Dec 13;450(7172):1091-5
18046333
Exp Parasitol. 2001 Jun;98(2):59-70
11465989
Genome Biol. 2009 Feb 13;10(2):R21
19216790
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16290-5
18852452
Nature. 2005 Nov 3;438(7064):103-7
16267556
Mol Biochem Parasitol. 2006 Sep;149(1):10-6
16730808
Mol Microbiol. 2006 Mar;59(5):1369-79
16468982
PLoS Biol. 2003 Oct;1(1):E5
12929205
Mol Biochem Parasitol. 2005 Nov;144(1):16-26
16115694
Science. 1989 Jun 9;244(4909):1184-6
2658061
Science. 2004 Dec 10;306(5703):1930-3
15591202
BMC Genomics. 2008 Feb 07;9:70
18257930
Nucleic Acids Res. 2004 Oct 26;32(19):5712-20
15507685
PLoS One. 2008 Feb 13;3(2):e1570
18270564
Bull World Health Organ. 1959;20(1):27-36
13638787
Genes Dev. 2006 May 15;20(10):1294-307
16702403
J Biol Chem. 2008 Jun 20;283(25):17030-8
18400754
Mol Biochem Parasitol. 2005 Nov;144(1):1-9
16085323